NASDAQ:ANIP

ANI Pharmaceuticals Earning Date

USA |NASDAQ |USD

ANIP Earnings Date

|
Report Date Period Ending EPS Forecast Last Quarter's EPS Last Year's EPS
Nov 3, 2021 Sep 2021 $0.83 $0.67 $0.97
Report Date Period Ending Revenue Forecast Last Quarter’s Revenue Last Year’s Revenue
Nov 3, 2021 Sep 2021 $49.70M $48.62M $52.98M

Ani Pharmaceuticals's next earnings date is Wednesday, Nov 3, 2021 for the fiscal quarter ending Sep 2021.

ANIP Earnings Date & History Chart

ANIP Earnings & Revenue Forecast

ANIP Earnings Forecast

|
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 2 $0.82 $0.80 $0.84
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 2 $3.38 $3.31 $3.46
Dec 2022 2 $3.87 $3.25 $4.49

ANIP Earnings Revision Trend

|
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Dec 2021 0 / 0 $0.82 $1.12 $1.10
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Dec 2021 0 / 0 $3.38 $3.45 $3.34
Dec 2022 0 / 0 $3.87 $4.12 $4.12

ANIP Revenue Forecast

|
Period End # of Analysts Revenue Forecast Low Revenue Forecast High Revenue Forecast
Dec 2021 2 $56.50M $54.70M $58.30M
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 2 $209.35M $207.00M $211.70M
Dec 2022 2 $243.70M $240.50M $246.90M

ANIP Earnings Date & Revenue History

ANIP Earnings History

|
Show More
Show More

ANIP Revenue History

|
Show More
Show More

Ani Pharmaceuticals Next Earnings Date & Report

ANIP Next Earnings Date & Report Preview: Sep 2021 (FQ)

ANIP's next earnings date is Wednesday, Nov 3, 2021 for the fiscal quarter ending Sep 30, 2021.

According to 2 analysts, the average EPS estimation for Ani Pharmaceuticals's next quarterly earnings is $0.83, with a low EPS estimation of $0.69, and a high estimation of $0.97.

Over the last 1 month, EPS estimates have seen 0 upward revisions and 0 downward. The EPS 1 month trend is $0.83, the last 2 month trend is $0.75, and the 3 month trend is $0.82.

Based on 2 analysts, the average revenue estimation is $49.70M, with a low revenue estimation of $49.10M, and a high estimation of $50.30M.

Ani Pharmaceuticals Previous Earnings Dates & Reports

ANIP Previous Earnings Date & Report Recap: Jun 2021 (FQ)

Ani Pharmaceuticals's previous earnings date was Aug 6, 2021 for its fiscal quarter ended Jun 30, 2021.

ANIP's earnings per share (EPS) was $0.67, beating the consensus analysts forecast of $0.61 by 10.74%.

The EPS was lower than the previous fiscal quarter (Mar 2021) by -35.58%, and lower than the same period a year before (Jun 2020) by -2.90%.

Revenues were $48.62M, better than the forecast of $48.05M by 1.20%, down by -10.81% from the previous quarter , and up by 0.32% from the same period last year.

The company reported a net income of $-14.11M.

Free cash flow for the quarter was $19.28K , compared to $19.93M last quarter and $18.03M a year before.

ANIP ended the quarter with $204.71M in total debt, an increase of 11.60% compared to the previous quarter, and an increase of 7.62% compared to the same quarter a year before.

ANIP Previous Earnings Date & Report Recap: Dec 2020 (FY)

Ani Pharmaceuticals's previous annual earnings date was Mar 9, 2021 for its fiscal year ended Dec 31, 2020.

ANIP's earnings per share (EPS) was $3.50, missing the consensus analysts forecast of $3.65 by -4.11% , and lower than the previous year's EPS (Dec 2019) by -30.69%.

Revenues were $208.47M, better than the forecast of $205.37M by 1.51%, and up by 0.93% from previous year's revenue.

The company reported a net income of $-22.55M.

Ani Pharmaceuticals reported a free cash flow of $-53.05M for its fiscal year, compared to $18.08M a year ago.

The company ended the fiscal year with $185.69M in total debt, a decrease of -0.03% compared to the previous year.